Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

AT 2153

Known as: AT-2153 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

probimanerazoxane

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Cell biological manifestations of bisdioxopiperazines treatment of human tumor cell lines in culture.
British developed Bisdioxopiperazine compound (Biz compounds) {ICRF-159 or ICRF-187 (razoxane, Raz)} which was the first agent… Expand
Is this relevant?
1993
1993
[Distribution of 14C labeled at dioxopiperazine or methyl morpholine group of probimane by whole body autoradiography].
Probimane (AT-2153) is a new anticancer compound. It was first developed in this Institute. It is effective against mouse tumors… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE